Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies

The mammalian skull vault is constructed principally from five bones: the paired frontals and parietals, and the unpaired interparietal. These bones abut at sutures, where most growth of the skull vault takes place. Sutural growth involves maintenance of a population of proliferating osteoprogenitor cells which differentiate into bone matrix‐secreting osteoblasts. Sustained function of the sutures as growth centres is essential for continuous expansion of the skull vault to accommodate the growing brain. Craniosynostosis, the premature fusion of the cranial sutures, occurs in 1 in 2500 children and often presents challenging clinical problems. Until a dozen years ago, little was known about the causes of craniosynostosis but the discovery of mutations in the MSX2, FGFR1, FGFR2, FGFR3, TWIST1 and EFNB1 genes in both syndromic and non‐syndromic cases has led to considerable insights into the aetiology, classification and developmental pathology of these disorders. Investigations of the biological roles of these genes in cranial development and growth have been carried out in normal and mutant mice, elucidating their individual and interdependent roles in normal sutures and in sutures undergoing synostosis. Mouse studies have also revealed a significant correspondence between the neural crest–mesoderm boundary in the early embryonic head and the position of cranial sutures, suggesting roles for tissue interaction in suture formation, including initiation of the signalling system that characterizes the functionally active suture.

[1]  S. Higashijima,et al.  Two FGF-receptor homologues of Drosophila: one is expressed in mesodermal primordium in early embryos. , 1993, Development.

[2]  G. B. Schaefer,et al.  Craniofrontonasal dysplasia. , 1998, Ear, nose, & throat journal.

[3]  N. Itoh,et al.  FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. , 2002, Genes & development.

[4]  S. Fraser,et al.  Vital dye analysis of cranial neural crest cell migration in the mouse embryo. , 1992, Development.

[5]  Robert J Linhardt,et al.  Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. , 2003, Human molecular genetics.

[6]  I. Daar,et al.  Morphogenetic movements underlying eye field formation require interactions between the FGF and ephrinB1 signaling pathways. , 2004, Developmental cell.

[7]  K. Eto,et al.  Mammalian craniofacial embryology in vitro. , 1997, The International journal of developmental biology.

[8]  W. Reardon,et al.  Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome , 1995, Nature Genetics.

[9]  Gary W. Harding,et al.  Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 , 1996, Nature Genetics.

[10]  I. Mathijssen,et al.  Tracing craniosynostosis to its developmental stage through bone center displacement. , 1999, Journal of craniofacial genetics and developmental biology.

[11]  A. Wilkie,et al.  FGFR3 P250R Mutation Increases the Risk of Reoperation in Apparent ‘Nonsyndromic’ Coronal Craniosynostosis , 2005, The Journal of craniofacial surgery.

[12]  C. Dickson,et al.  A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Rice,et al.  Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault , 2003, Development.

[14]  E. Zackai,et al.  Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes , 1996, Nature Genetics.

[15]  G. Waksman,et al.  Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Pedersen,et al.  Clonal analysis of cell fate during gastrulation and early neurulation in the mouse. , 1992, Ciba Foundation symposium.

[17]  R. Krumlauf,et al.  Hox genes and pattern formation in the branchial region of the vertebrate head. , 1993, Trends in genetics : TIG.

[18]  Gillian M Morriss-Kay,et al.  A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Deng,et al.  A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis , 2003 .

[20]  Nobuyuki Itoh,et al.  Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities. , 2004, Human molecular genetics.

[21]  D. Rice,et al.  Summary Msx 2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault , 2003 .

[22]  A. Bloch-Zupan,et al.  The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. , 1998, Human molecular genetics.

[23]  J. Rossant,et al.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. , 1998, Genes & development.

[24]  R. Behringer,et al.  Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. , 2002, Developmental biology.

[25]  S. Werner,et al.  Fibroblast Growth Factor (FGF) Receptor 1-IIIb Is a Naturally Occurring Functional Receptor for FGFs That Is Preferentially Expressed in the Skin and the Brain* , 2000, The Journal of Biological Chemistry.

[26]  A. N. Meyer,et al.  Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Wilkie,et al.  Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. , 1999, Development.

[28]  Christine Vincent,et al.  Negative effect of Hox gene expression on the development of the neural crest-derived facial skeleton. , 2002, Development.

[29]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[30]  E. Jabs,et al.  A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis , 1993, Cell.

[31]  R. Maxson,et al.  The molecular basis of Boston-type craniosynostosis: the Pro148-->His mutation in the N-terminal arm of the MSX2 homeodomain stabilizes DNA binding without altering nucleotide sequence preferences. , 1996, Human molecular genetics.

[32]  D. Ornitz,et al.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. , 2002, Genes & development.

[33]  B. Thisse,et al.  The twist gene: isolation of a Drosophila zygotic gene necessary for the establishment of dorsoventral pattern. , 1987, Nucleic acids research.

[34]  D. Ornitz Regulation of chondrocyte growth and differentiation by fibroblast growth factor receptor 3. , 2001, Novartis Foundation symposium.

[35]  E. Olson,et al.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth , 2003, Development.

[36]  A. Munnich,et al.  Mutations in the basic domain and the loop–helix II junction of TWIST abolish DNA binding in Saethre–Chotzen syndrome , 2001, FEBS letters.

[37]  P. Bénit,et al.  Mutations of the TWIST gene in the Saethre-Chotzene syndrome , 1997, Nature Genetics.

[38]  Sue Malcolm,et al.  Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome , 1994, Nature Genetics.

[39]  W. Reardon,et al.  A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome , 1994, Nature Genetics.

[40]  R. Behringer,et al.  twist is required in head mesenchyme for cranial neural tube morphogenesis. , 1995, Genes & development.

[41]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[42]  R. Friesel,et al.  Constitutive Activation of Fibroblast Growth Factor Receptor-2 by a Point Mutation Associated with Crouzon Syndrome (*) , 1995, The Journal of Biological Chemistry.

[43]  J. Heath,et al.  Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. , 1998, Human molecular genetics.

[44]  D. Wilkinson,et al.  Roles of Eph receptors and ephrins in segmental patterning. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[45]  R. Krumlauf,et al.  Patterning the cranial neural crest: Hinbrain segmentation and hox gene plasticity , 2000, Nature Reviews Neuroscience.

[46]  M. Longaker,et al.  The BMP antagonist noggin regulates cranial suture fusion , 2003, Nature.

[47]  C. Deng,et al.  A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. , 2000, Human molecular genetics.

[48]  R. Klein,et al.  Control of skeletal patterning by ephrinB1-EphB interactions. , 2003, Developmental cell.

[49]  S. Iseki,et al.  Tissue origins and interactions in the mammalian skull vault. , 2002, Developmental biology.

[50]  F. Rijli,et al.  Cranial neural crest and the building of the vertebrate head , 2003, Nature Reviews Neuroscience.

[51]  J. Heath,et al.  Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. , 1997, Development.

[52]  D. Wilkinson,et al.  Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. , 2004, Developmental cell.

[53]  Michael T Longaker,et al.  Sutural bone deposition rate and strain magnitude during cranial development. , 2004, Bone.

[54]  F. Tsai,et al.  Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data. , 1999, American journal of medical genetics.

[55]  L. K. Brown,et al.  Myles textbook for midwives , 1989 .

[56]  M. Justice,et al.  A twist code determines the onset of osteoblast differentiation. , 2004, Developmental cell.

[57]  A. Wilkie Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations. , 2005, Cytokine & growth factor reviews.

[58]  J. Heath,et al.  Expression patterns of fibroblast growth factors-18 and -20 in mouse embryos is suggestive of novel roles in calvarial and limb development , 2002, Mechanisms of Development.

[59]  P. Tam,et al.  A morphological and experimental study of the mesencephalic neural crest cells in the mouse embryo using wheat germ agglutinin-gold conjugate as the cell marker. , 1988, Development.

[60]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[61]  M. C. Johnston,et al.  Migration of cranial neural crest cells in a cell-free hyaluronate-rich matrix. , 1975, Developmental biology.

[62]  E. Green,et al.  Mutations in TWIST, a basic helix–loop–helix transcription factor, in Saethre-Chotzen syndrome , 1997, Nature Genetics.

[63]  J. Heath,et al.  Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Michael T. Longaker,et al.  Studies in Cranial Suture Biology: IV. Temporal Sequence of Posterior Frontal Cranial Suture Fusion in the Mouse , 1996, Plastic and reconstructive surgery.

[65]  G. Morriss-Kay,et al.  Migration of cranial neural crest cells to the pharyngeal arches and heart in rat embryos , 1992, Cell and Tissue Research.

[66]  M. Pines,et al.  The IIIc alternative of Fgfr2 is a positive regulator of bone formation. , 2002, Development.

[67]  N. Itoh,et al.  Evolution of the Fgf and Fgfr gene families. , 2004, Trends in genetics : TIG.

[68]  A. McMahon,et al.  Fate of the mammalian cardiac neural crest. , 2000, Development.

[69]  D. Rice,et al.  Integration of FGF and TWIST in calvarial bone and suture development. , 2000, Development.

[70]  J. Hirsch,et al.  Intracranial pressure in craniostenosis. , 1982, Journal of neurosurgery.

[71]  A. Wilkie Craniosynostosis: genes and mechanisms. , 1997, Human molecular genetics.

[72]  M. Kirby,et al.  Neural crest cells contribute to normal aorticopulmonary septation. , 1983, Science.

[73]  W. Burgdorf Syndromes of the head and neck. 4th ed , 2002 .

[74]  J. Heath,et al.  Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics , 2003, Development.

[75]  A. McMahon,et al.  Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. , 2000, Development.

[76]  G. Morriss-Kay,et al.  Prorhombomeric subdivision of the mammalian embryonic hindbrain: is it functionally meaningful? , 1997, The International journal of developmental biology.

[77]  G. Morriss-Kay,et al.  Analysis of cranial neural crest cell migration and early fates in postimplantation rat chimaeras. , 1986, Journal of embryology and experimental morphology.

[78]  J. Clayton-Smith Syndromes of the Head and Neck , 1993 .

[79]  David G. Wilkinson,et al.  Multiple roles of eph receptors and ephrins in neural development , 2001, Nature Reviews Neuroscience.

[80]  C. MacArthur,et al.  Receptor Specificity of the Fibroblast Growth Factor Family* , 1996, The Journal of Biological Chemistry.

[81]  W. Reardon,et al.  Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes , 1995, Nature Genetics.

[82]  S. Robertson,et al.  Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[83]  E. Carver,et al.  Craniosynostosis in Twist heterozygous mice: A model for Saethre‐Chotzen syndrome , 2002, The Anatomical record.

[84]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[85]  I. Daar,et al.  Fibroblast Growth Factor Receptor-Mediated Rescue of x-Ephrin B1-Induced Cell Dissociation in XenopusEmbryos , 2000, Molecular and Cellular Biology.

[86]  E. Zackai,et al.  De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. , 1999, American journal of human genetics.

[87]  B. Shilo,et al.  Heartless, a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. , 1996, Genes & development.

[88]  P. Gakunga,et al.  Transforming growth factor‐β2 and TGF‐β3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis , 2000 .

[89]  D. Johnson,et al.  Structural and functional diversity in the FGF receptor multigene family. , 1993, Advances in cancer research.

[90]  K. Eto,et al.  The contribution of both forebrain and midbrain crest cells to the mesenchyme in the frontonasal mass of mouse embryos. , 1994, Developmental biology.

[91]  R. Adams,et al.  Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome. , 2004, American journal of human genetics.

[92]  P. Gakunga,et al.  Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[93]  P. Marie,et al.  A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. , 2005, Human molecular genetics.

[94]  M. Longaker,et al.  Regional Dura Mater Differentially Regulates Osteoblast Gene Expression , 2003, The Journal of craniofacial surgery.

[95]  G. Morriss-Kay,et al.  The effects of Streptomyces hyaluronidase on tissue organization and cell cycle time in rat embryos. , 1986, Journal of embryology and experimental morphology.